Development of lupus‐related side‐effects in patients with early RA during sulphasalazine treatment—the role of IL‐10 and HLA (Q57350977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Lars Klareskog

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

I Gunnarsson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Nordmark

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Hassan Bakri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G Gröndal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Forslid

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Ringertz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

886-893

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Predisposing factors in sulphasalazine-induced systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.8.886

10.1093/RHEUMATOLOGY/39.8.886

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10952745%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference